✅ 2.4M subscribers
✅ Personalized GLP-1 programs
✅ Expansion into longevity & hormonal health
But at $44+ per share, the price already assumes perfection:
– ~4.2x forward P/S
– ~56x trailing P/E
– -$69M in Q2 FCF
– Gross margin down YoY
📌 The question isn’t “is it a great company?”
It’s: “is it worth $10B today?”
My fair value: $33–36
$100 is a dream. Not a target.